In an election year, voters are likely to hear candidates laud even their own most contentious policy agendas as legislative victories. A fact check is in order, however, for the healthcare provisions in the Biden administration’s Inflation Reduction Act. What voters aren’t being told is that one key line item in the act will have a huge impact on a vital treatment option for seniors.

With little admiration for the value of these treatments, the Inflation Reduction Act essentially discourages their creation, and while not intentional, this policy comes at the expense of patients. Pill-form drugs, known as “small-molecule drugs” in the science community, treat everything from neurological diseases such as Alzheimer’s to allergies and high cholesterol.